Annual Total Liabilities
$189.16 M
-$53.13 M-21.93%
December 31, 2023
Summary
- As of February 8, 2025, MRSN annual total liabilities is $189.16 million, with the most recent change of -$53.13 million (-21.93%) on December 31, 2023.
- During the last 3 years, MRSN annual total liabilities has risen by +$143.84 million (+317.45%).
- MRSN annual total liabilities is now -21.93% below its all-time high of $242.28 million, reached on December 31, 2022.
Performance
MRSN Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$168.48 M
-$2.22 M-1.30%
September 30, 2024
Summary
- As of February 8, 2025, MRSN quarterly total liabilities is $168.48 million, with the most recent change of -$2.22 million (-1.30%) on September 30, 2024.
- Over the past year, MRSN quarterly total liabilities has dropped by -$42.23 million (-20.04%).
- MRSN quarterly total liabilities is now -30.46% below its all-time high of $242.28 million, reached on December 31, 2022.
Performance
MRSN Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
MRSN Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.9% | -20.0% |
| 3 y3 years | +317.4% | -20.0% |
| 5 y5 years | +171.4% | -20.0% |
MRSN Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -21.9% | +124.2% | -30.5% | +99.7% |
| 5 y | 5-year | -21.9% | +547.3% | -30.5% | +476.5% |
| alltime | all time | -21.9% | +547.3% | -30.5% | +565.5% |
Mersana Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $168.48 M(-1.3%) |
| Jun 2024 | - | $170.70 M(+0.2%) |
| Mar 2024 | - | $170.39 M(-9.9%) |
| Dec 2023 | $189.16 M(-21.9%) | $189.16 M(-10.2%) |
| Sep 2023 | - | $210.71 M(-4.7%) |
| Jun 2023 | - | $221.20 M(-4.6%) |
| Mar 2023 | - | $231.90 M(-4.3%) |
| Dec 2022 | $242.28 M(+187.2%) | $242.28 M(+7.9%) |
| Sep 2022 | - | $224.62 M(+89.8%) |
| Jun 2022 | - | $118.32 M(+0.5%) |
| Mar 2022 | - | $117.74 M(+39.6%) |
| Dec 2021 | $84.37 M(+86.2%) | $84.37 M(+36.0%) |
| Sep 2021 | - | $62.04 M(+6.6%) |
| Jun 2021 | - | $58.17 M(+16.4%) |
| Mar 2021 | - | $49.97 M(+10.3%) |
| Dec 2020 | $45.31 M | $45.31 M(+23.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $36.82 M(-0.4%) |
| Jun 2020 | - | $36.95 M(+12.8%) |
| Mar 2020 | - | $32.77 M(+12.1%) |
| Dec 2019 | $29.22 M(-58.1%) | $29.22 M(+2.1%) |
| Sep 2019 | - | $28.61 M(-7.3%) |
| Jun 2019 | - | $30.87 M(+21.9%) |
| Mar 2019 | - | $25.32 M(-63.7%) |
| Dec 2018 | $69.71 M(+14.8%) | $69.71 M(+8.0%) |
| Sep 2018 | - | $64.52 M(+5.4%) |
| Jun 2018 | - | $61.22 M(+3.4%) |
| Mar 2018 | - | $59.21 M(-2.5%) |
| Dec 2017 | $60.72 M(-62.2%) | $60.72 M(+2.4%) |
| Sep 2017 | - | $59.27 M(-62.2%) |
| Jun 2017 | - | $156.87 M(+145.6%) |
| Mar 2017 | - | $63.87 M(-60.3%) |
| Dec 2016 | $160.71 M(+181.4%) | $160.71 M |
| Dec 2015 | $57.10 M | - |
FAQ
- What is Mersana Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Mersana Therapeutics?
- What is Mersana Therapeutics annual total liabilities year-on-year change?
- What is Mersana Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Mersana Therapeutics?
- What is Mersana Therapeutics quarterly total liabilities year-on-year change?
What is Mersana Therapeutics annual total liabilities?
The current annual total liabilities of MRSN is $189.16 M
What is the all time high annual total liabilities for Mersana Therapeutics?
Mersana Therapeutics all-time high annual total liabilities is $242.28 M
What is Mersana Therapeutics annual total liabilities year-on-year change?
Over the past year, MRSN annual total liabilities has changed by -$53.13 M (-21.93%)
What is Mersana Therapeutics quarterly total liabilities?
The current quarterly total liabilities of MRSN is $168.48 M
What is the all time high quarterly total liabilities for Mersana Therapeutics?
Mersana Therapeutics all-time high quarterly total liabilities is $242.28 M
What is Mersana Therapeutics quarterly total liabilities year-on-year change?
Over the past year, MRSN quarterly total liabilities has changed by -$42.23 M (-20.04%)